Expression Profile and Diagnostic Significance of MicroRNAs in Papillary Thyroid Cancer
Authors:
- Mariusz RoguckiMRMariusz Rogucki
- Iwona SidorkiewiczISIwona Sidorkiewicz
- Magdalena NiemiraMNMagdalena Niemira
- Janusz Bogdan DzięciołJDJanusz Bogdan Dzięcioł
- Angelika BuczyńskaABAngelika Buczyńska
- Agnieszka AdamskaAAAgnieszka Adamska
- Katarzyna SiewkoKSKatarzyna Siewko
- Maria KościuszkoMKMaria Kościuszko
- Katarzyna MaliszewskaKMKatarzyna Maliszewska
- Anna WójcickaAWAnna Wójcicka
- Jakub SupronikJSJakub Supronik
- Małgorzata SzelachowskaMSMałgorzata Szelachowska
Open Access
Abstract
The incidence of papillary thyroid cancer (PTC) has increased in recent years. To improve the diagnostic management of PTC, we propose the use of microRNAs (miRNAs) as a biomarker. Our aim in this study was to evaluate the miRNA expression pattern in PTC using NanoString technology. We identified ten miRNAs deregulated in PTC compared with reference tissue: miR-146b-5p, miR-221-3p, miR-221-5p, miR-34-5p, miR-551b-3p, miR-152-3p, miR-15a-5p, miR-31-5p, and miR-7-5p (FDR < 0.05; |fold change (FC)| ≥ 1.5). The gene ontology (GO) analysis of differentially expressed miRNA (DEM) target genes identified the predominant involvement of epidermal growth factor receptor (EGFR), tyrosine kinase inhibitor resistance, and pathways in cancer in PTC. The highest area under the receiver operating characteristic (ROC) curve (AUC) for DEMs was found for miR-146-5p (AUC = 0.770) expression, indicating possible clinical applicability in PTC diagnosis. The combination of four miRNAs (miR-152-3p, miR-221-3p, miR-551b-3p, and miR-7-5p) showed an AUC of 0.841. Validation by real-time quantitative polymerase chain reactions (qRT-PCRs) confirmed our findings. The introduction of an miRNA diagnostic panel based on the results of our study may help to improve therapeutic decision making for questionable cases. The use of miRNAs as biomarkers of PTC may become an aspect of personalized medicine.Keywords
Funding Information
- Uniwersytet Medyczny w Bialymstoku (SUB/1/DN/22/002/1150, 07/MSD/2019)
- European Union (SUB/1/DN/22/002/1150, 07/MSD/2019)
This publication has 92 references indexed in Scilit:
- Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated withBRAFMutation and Clinicopathological Features in Chinese PatientsInternational Journal of Endocrinology, 2013
- MicroRNA as a Diagnostic Tool in Fine-Needle Aspiration Biopsy of Thyroid NodulesThe Oncologist, 2012
- MicroRNA profiling: approaches and considerationsNature Reviews Genetics, 2012
- Intercellular Adhesion Molecule-1 (ICAM-1) is Upregulated in Aggressive Papillary Thyroid CarcinomaAnnals of Surgical Oncology, 2011
- Uncommon GNAQ, MMP8, AKT3, EGFR, and PIK3R1 Mutations in Thyroid CancersEndocrine Pathology, 2011
- The Bethesda System for Reporting Thyroid CytopathologyAmerican Journal of Clinical Pathology, 2009
- Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examinationEuropean Journal of Clinical Investigation, 2009
- Epidermal growth factor receptor gene mutations in papillary thyroid carcinomaInternational Journal of Cancer, 2009
- The role of microRNA genes in papillary thyroid carcinomaProceedings of the National Academy of Sciences, 2005
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003